SCHEMBL24040352

SCHEMBL24040352

CCc1cn([C@H]2C[C@@H](O)[C@@H](CO)O2)c2ncnc(N)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.51
ADK P55263 1/20 0.51
DNMT1 P26358 4/20 0.49
ADRB1 P08588 1/20 0.49
FPR2 P25090 2/20 0.49
DNMT3B Q9UBC3 2/20 0.49
TK2 O00142 1/20 0.48
TK1 P04183 1/20 0.48
PNP P00491 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
HTT P42858 1/20 0.47
PDE4D Q08499 1/20 0.47
PDE3A Q14432 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
PRMT5 O14744 3/20 0.47
METTL3 Q86U44 2/20 0.47
CA2 P00918 2/20 0.46
ATG7 O95352 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30179160 0.91 ADK (0.52) HIF1AADKDNMT1ADRB1FPR2
SCHEMBL16378847 0.87 ADK (0.54) HIF1AADKDNMT1ADRB1PNP
SCHEMBL17106694 0.87 ADK (0.54) HIF1AADKDNMT1ADRB1PNP
SCHEMBL23019063 0.87 ADK (0.54) HIF1AADKDNMT1ADRB1PNP
SCHEMBL23745928 0.85 ADK (0.54) HIF1AADKDNMT1ADRB1FPR2
SCHEMBL24127868 0.85 ADK (0.54) HIF1AADKDNMT1ADRB1FPR2
SCHEMBL18490333 0.84 ADK (0.52) HIF1AADKDNMT1ADRB1PNP
SCHEMBL20419182 0.84 PRMT5 (0.59) HIF1AADKDNMT1ADRB1PNP
SCHEMBL17114379 0.84 PRMT5 (0.59) HIF1AADKDNMT1ADRB1PNP
SCHEMBL15740255 0.84 ADK (0.56) HIF1AADKDNMT1ADRB1TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11180522-B2 Disulfide-linked reversible terminators CENTRILLION TECHNOLOGY HOLDINGS CORPORATION (KY) 2021-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11180522-B2 Disulfide-linked reversible terminators RNGTT, NSUN3, NSUN2 HIF1A 4640/4885ADK 1213/4885DNMT1 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.